Corwin Dale Hooks
CIK 1665347 · Chief Commercial Officer · last filed 2026-03-09
Corwin Dale Hooks is a Chief Commercial Officer who has filed 20 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for SPRB, was dated Mar 9, 2026. Across all open-market trades the lifetime net is −$206.9K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
20
-$206.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRB | Chief Commercial Officer | — | $51.89 | — | $0 | 1 | 2026-03-09 |
| Applied Therapeutics, Inc. (APLT) Delisted | Chief Commercial Officer | 5,753 | $0.10 | $593 | $0 | 3 | 2026-02-03 |
| Clovis Oncology, Inc. (CLVS) Delisted | See Remarks | 19 | $0.08 | $2 | -$206.9K | 16 | 2018-12-27 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-09 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2026-02-03 | Applied Therapeutics, Inc. (APLT) Delisted | Mixed | −555,753 | $0 | EDGAR |
| 2025-03-26 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +250,000 | $0 | EDGAR |
| 2024-04-15 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2018-12-27 | Clovis Oncology, Inc. (CLVS) Delisted | Sell (S) | −2,150 | -$164.2K | EDGAR |
| 2018-12-27 | Clovis Oncology, Inc. (CLVS) Delisted | Sell (S) | −939 | -$42.7K | EDGAR |
| 2018-09-07 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +230 | -$8.5K | EDGAR |
| 2018-08-28 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +435 | -$15.3K | EDGAR |
| 2018-06-08 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +233 | -$11.2K | EDGAR |
| 2018-06-01 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +425 | -$21.6K | EDGAR |